Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 409 for center for individualized medicine

Edit search filters
  1. Study To Evaluate The Safety And Effectiveness Of Axicabtagene Ciloleucel In Combination With Utomilumab In Adults With Relapsed/Refractory Large B-cell Lymphoma

    Rochester, MN

  2. Tazemetostat In Combination With Doxorubicin As Frontline Therapy For Advanced Epithelioid Sarcoma

    Jacksonville, FL

  3. Study Of Lenzilumab And Axicabtagene Ciloleucel In Subjects With Relapsed Or Refractory Large B-cell Lymphoma

    Rochester, MN

  4. A Study Of Hypofractionated Radiotherapy To The Whole Breast Alone Before Breast Conserving Surgery

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. A Study Of CAD106 And CNP520 Versus Placebo In Participants At Risk For The Onset Of Clinical Symptoms Of Alzheimer's Disease

    Jacksonville, FL

  6. Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

    Rochester, MN

  7. A Study Of CAD106 And CNP520 Versus Placebo In Participants At Risk For The Onset Of Clinical Symptoms Of Alzheimer's Disease

    Jacksonville, FL

  8. A Study Of Afatinib Treatment For Patients With Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 Or Older

    Scottsdale/Phoenix, AZ

  9. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection

    Scottsdale/Phoenix, AZ

  10. A Study Of Daratumumab, Bortezomib, Lenalidomide And Dexamethasone (DVRd) Followed By Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide And Dexamethasone (DVRd) Followed By Autologous Stem Cell Transplant (ASCT) In Participants With Newly Diagnosed Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer